首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:High blood pressure & cardiovascular prevention

缩写:

ISSN:1120-9879

e-ISSN:1179-1985

IF/分区:2.9/Q2

文章目录 更多期刊信息

共收录本刊相关文章索引828条
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Davide Grassi,Giovambattista Desideri,Anna Vittoria Di Giacomantonio et al. Davide Grassi et al.
There is an increasing prevalence of gout and hyperuricemia worldwide. Gout confers a significant individual and social burden and is increasingly recognized as a prevalent chronic disease state requiring appropriate long-term management. G...
Alberto Milan,Eleonora Avenatti,Erika Della Valle et al. Alberto Milan et al.
Objective: Volume overload is typical of haemodialysis patients; correct volume status evaluation is crucial in achieving blood pressure homeostasis, hypertension management and good treatment planning. This study evaluat...
Agostino Virdis,Lorenzo Ghiadoni,Stefano Taddei;Italian Society of Hypertension (SIIA) Agostino Virdis
Results from recent observational studies conducted in our country and including approximately 160,000 patients with hypertension, reported that only 37 % of patients achieve effective blood pressure control under treatment. These data conf...
Massimo Volpe,Alejandro de la Sierra,Reinhold Kreutz et al. Massimo Volpe et al.
Hypertension is a major modifiable risk for the development of cardiovascular, cerebrovascular and renal diseases. Thus, effective treatment of high blood pressure is an important strategy for reducing disease burden; however, in spite of t...
Paolo Palatini Paolo Palatini
A number of studies have shown that masked hypertension (MH) confers an increased risk of target organ damage and of cardiovascular events suggesting that patients with MH would benefit from antihypertensive treatment. However, there is no ...
Harold Bays,Dingliang Zhu,Helmut Schumacher Harold Bays
Lowering blood pressure (BP) in patients with high blood pressure reduces cardiovascular risk. Studies support health benefits when BP goals are achieved earlier in the course of treatment. Many patients require combination therapy to achie...
Francesca Viazzi,Giovanna Leoncini,Elena Ratto et al. Francesca Viazzi et al.
Asymptomatic mild hyperuricemia has been reported in association with a number of conditions associated with chronic kidney disease, including hypertension, insulin resistance, cerebrovascular and cardiac disease. Experimental studies indic...
Gian Paolo Rossi,Anna Dalla Cà;Italian Society of Hypertension Gian Paolo Rossi
Primary aldosteronism is the most common form of endocrine hypertension and is highly prevalent among patients with difficult to control high blood pressure. In the presence of a high sodium intake primary aldosteronism carries has detrimen...
Carolina De Ciuceis,Claudia Rossini,Elisa La Boria et al. Carolina De Ciuceis et al.
Low grade inflammation may have a key role in the pathogenesis of hypertension and cardiovascular disease. Several studies showed that both innate and adaptive immune systems may be involved, being T cells the most important players. Partic...
Stefano Omboni,Ettore Malacco,Jean-Michel Mallion et al. Stefano Omboni et al.
Hypertension is a frequent condition among individuals over 65 years of age worldwide and is one of the most important risk factors for cardiovascular (CV) disease. Effective drug treatment of elderly hypertensives is usually associated wit...